AI assistant
Hansa Biopharma Major Shareholding Notification 2020
3057_iss_2020-11-25_f69e04d4-21b9-410b-afb3-643df45afe5b.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Hansa Biopharma AB
Holder
Redmile Group, LLC
Instrument
| Instrument | Ordinary shares SE0002148817 |
|---|---|
| Before the transaction | |
| Shares | 4,410,608 |
| Voting rights | 4,410,608 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 23/11/2020 |
| Limit for number of votes | 10 % |
| After the transaction | |
| Quantity | |
| Shares | 4,491,422 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 4,491,422 |
| Percentage | |
| Directly held shares | 9.78632 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 10.06693 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 10.06693 % | 4,491,422 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 10.06693 % | 4,491,422 |
Chain of controlling companies
| Voting rights % Voting rights Company | ||
|---|---|---|
| 907,522 | 2.03409 | Redmile Capital Fund, LP |
| 1,819,476 4.07812 | Redmile Capital Offshore Master Fund, Ltd. | |
| 82,568 | 0.18507 | Redmile Capital Offshore Master Fund (ERISA), Ltd. |
| 529,420 | 1.18663 | Redmile Capital Offshore II Master Fund, Ltd. |
| 712,987 | 1.59807 | Redmile Strategic Master Fund, LP |
| 288,271 | 0.64612 | RedCo I, L.P. |
| 151,178 | 0.33885 | Map 20 Segregated Portfolio a Segregated Portfolio of LMA SPC |
Group total holdings
Voting rights 4,491,422 Percentage of voting rights 10.06693
Published
25/11/2020 11:26
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25